Suicide deaths among youth following antidepressant boxed warnings

warning
Credit: CC0 Public Domain

A public health advisory issued by the US Food and Drug Administration (FDA) in 2003, followed by drug label warnings, indicated that children and adolescents taking antidepressants were at increased risk of developing suicidal thoughts and behaviors. Research has shown that these warnings reduced the diagnosis and treatment of depression among young people. Now, a new study suggests that the warnings may also have contributed to an increase in suicide deaths among youth.

The authors of the study, which is published in Psychiatric Research and Clinical Practice, estimate that there may have been 5,958 excess suicides nationally by 2010 among 43 million adolescents and 21 million .

"Our findings suggest the boxed warnings may have contributed to the very thing the FDA was trying to prevent. More than two-thirds of depressed teens do not receive any depression care whatsoever, an issue now further exacerbated by COVID-19. We strongly recommend the FDA reexamine the use of these warnings," said principal investigator Stephen Soumerai, ScD, of Harvard Medical School and the Harvard Pilgrim Health Care Institute.


Explore further

Unintended danger from antidepressant warnings

More information: Psychiatric Research and Clinical Practice, DOI: 10.1176/appi.prcp.20200012
Provided by Wiley
Citation: Suicide deaths among youth following antidepressant boxed warnings (2020, October 7) retrieved 25 November 2020 from https://medicalxpress.com/news/2020-10-suicide-deaths-youth-antidepressant.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments